CO114 Real-World Reductions in Acute Medication Use for Patients with Migraine Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.210
https://www.valueinhealthjournal.com/article/S1098-3015(22)00411-9/fulltext
Section Title :
Section Order :
10178
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00411-9&doi=10.1016/j.jval.2022.04.210